CSL pays $355 million upfront to advance Alentis’ fibrosis antibody
The global partnership will fund later-stage testing of lixudebart across rare kidney and liver diseases. Its anti-fibrotic promise remains unproven in a pivotal trial.
Read storyThe latest signals.
Independent reporting and analysis across technology, science, startups and invention.
Seventeen countries endorse a Kyoto blueprint for AI-driven science
The Kyoto Vision backs new research-funding models, wider access to AI and stronger scientific integrity. It is a political signal rather than a funded or binding implementation plan.
Read story
Novartis licenses Abogen’s mRNA engager in deal with a $7.8 billion ceiling
Novartis will pay $575 million upfront for worldwide rights to ABO2203 and options on other Abogen RNA programs. The much larger headline figure depends on development, approvals and commercialization that may never occur.
Read story
Moderna loses a Bayh–Dole shield in Northwestern’s vaccine patent case
A Delaware judge ruled that the federal government’s license to university inventions does not automatically protect a private supplier. Moderna’s separate government-contract defense—and the underlying infringement claims—remain unresolved.
Read story
White House gives new ‘Super Intelligence Force’ 120 days to map AI oversight
A task force led by U.S. intelligence chief Jay Clayton will examine AI risks, opportunities and the federal government’s role. Its short mandate raises an immediate test: whether it can turn broad coordination into verifiable policy.
Read story
Appeals court freezes Minnesota’s AI ‘nudification’ ban in xAI case
The Eighth Circuit has paused enforcement of a first-of-its-kind state law aimed at AI tools that generate realistic intimate images of identifiable people. The injunction is temporary and does not settle the constitutional dispute.
Read story
Broadcom may lend Anthropic up to $42 billion to finance TPU capacity
A prospective convertible facility disclosed in Anthropic’s IPO papers shows how AI infrastructure is becoming a financing structure as well as a technology stack. The $42 billion is a ceiling, not money already borrowed or spent.
Read story
First Solar widens its TOPCon patent campaign to JA Solar and a Corning unit
A Delaware lawsuit adds JA Solar companies and American Panel Solutions to a growing dispute over a manufacturing patent for high-efficiency crystalline-silicon cells. The filing could test how broadly one of solar's most commercially important process portfolios reaches.
Read story
Volantis raises $88 million to attack AI’s memory wall with light
The semiconductor startup is building an optical link between processors and large pools of memory for AI inference. Its funding is real; its most striking speed and scale figures remain unverified engineering targets.
Read story